Kopanos, S.; Filippatos, C.; Rousakis, P.; Kostopoulos, I.V.; Baxevanis, C.N.; Tentolouris, A.; Gavriatopoulou, M.; Tsitsilonis, O.; Ntanasis-Stathopoulos, I.
Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Cancers 2025, 17, 3675.
https://doi.org/10.3390/cancers17223675
AMA Style
Kopanos S, Filippatos C, Rousakis P, Kostopoulos IV, Baxevanis CN, Tentolouris A, Gavriatopoulou M, Tsitsilonis O, Ntanasis-Stathopoulos I.
Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Cancers. 2025; 17(22):3675.
https://doi.org/10.3390/cancers17223675
Chicago/Turabian Style
Kopanos, Stylianos, Charalampos Filippatos, Pantelis Rousakis, Ioannis V. Kostopoulos, Constantin N. Baxevanis, Anastasios Tentolouris, Maria Gavriatopoulou, Ourania Tsitsilonis, and Ioannis Ntanasis-Stathopoulos.
2025. "Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis" Cancers 17, no. 22: 3675.
https://doi.org/10.3390/cancers17223675
APA Style
Kopanos, S., Filippatos, C., Rousakis, P., Kostopoulos, I. V., Baxevanis, C. N., Tentolouris, A., Gavriatopoulou, M., Tsitsilonis, O., & Ntanasis-Stathopoulos, I.
(2025). Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Cancers, 17(22), 3675.
https://doi.org/10.3390/cancers17223675
